ELABS — Elliptic Laboratories ASA Income Statement
0.000.00%
Last trade - 00:00- NOK312.67m
- NOK282.72m
- NOK101.31m
Annual income statement for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | NAS | NAS | NAS | NAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 54.6 | 52.1 | 68.3 | 132 | 101 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 65.7 | 94.2 | 118 | 127 | 147 |
| Operating Profit | -11.1 | -42.1 | -49.9 | 4.71 | -45.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.1 | -39.3 | -47 | 17 | -58.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.2 | -33 | -38.1 | 8.96 | -138 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.2 | -33 | -38.1 | 8.96 | -138 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.2 | -33 | -38.1 | 8.96 | -138 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.104 | -0.309 | -0.354 | 0.085 | -1.32 |